A drug to treat advanced prostate cancer should be given to patients on the NHS, a health watchdog has said.
Abirateron, marketed as Zytiga, can extend the lives of late-stage cancer sufferers by more than three months.
The National Institute for Health and Clinical Excellence (Nice) revised its recommendations after fresh information from manufacturer Janssen, and the new draft guidance was welcomed by experts.
More top news
ITV News understands that Detective Sergeant Nick Bailey is close to being able to leave Salisbury District Hospital.
The blast happened on the road toward the Sakhi shrine where people gather to celebrate the New Year festival.
The retailer said it was "exploring" a company voluntary arrangement to help shore up its financial position.